A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma

NCT ID: NCT03769090

Last Updated: 2022-09-28

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

3132 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-12-13

Study Completion Date

2022-02-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a randomized, double-blind, multicenter, parallel-group, variable-length study to compare 2 doses of BDA MDI (PT027) with AS MDI (PT007) on the time to first severe asthma exacerbation in adult, adolescent, and pediatric subjects with moderate to severe asthma.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BDA MDI (PT027) 160/180 μg

Budesonide/albuterol sulfate, BDA MDI, PT027 high dose

Group Type EXPERIMENTAL

Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg

Intervention Type COMBINATION_PRODUCT

Budesonide/albuterol sulfate combination inhalation aerosol

BDA MDI (PT027) 80/180 μg

Budesonide/albuterol sulfate, BDA MDI, PT027 low dose

Group Type EXPERIMENTAL

Budesonide/albuterol sulfate metered-dose inhaler 80/180 μg

Intervention Type COMBINATION_PRODUCT

Budesonide/albuterol sulfate combination inhalation aerosol

AS MDI (PT007) 180 µg

Albuterol sulfate MDI, PT007

Group Type ACTIVE_COMPARATOR

Albuterol sulfate metered-dose inhaler 180 μg

Intervention Type DRUG

Albuterol sulfate inhalation aerosol

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg

Budesonide/albuterol sulfate combination inhalation aerosol

Intervention Type COMBINATION_PRODUCT

Budesonide/albuterol sulfate metered-dose inhaler 80/180 μg

Budesonide/albuterol sulfate combination inhalation aerosol

Intervention Type COMBINATION_PRODUCT

Albuterol sulfate metered-dose inhaler 180 μg

Albuterol sulfate inhalation aerosol

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Female or male aged ≥4 years at the time of informed consent
2. Physician diagnosis of asthma documented for at least 1 year
3. Receiving 1 of the following scheduled asthma maintenance therapies for 3 months with stable dosing for at least the last 4 weeks before Visit 1:

* Medium-to-high-dose inhaled corticosteroid (ICS)
* Medium-to-high-dose ICS and 1 additional maintenance therapy from the following: leukotriene receptor antagonists (LTRA), long-acting muscarinic antagonists (LAMA), or theophylline
* Low-to-high-dose ICS in combination with long-acting β2-adrenoreceptor agonist (LABA) with or without one additional maintenance therapy from the following: LTRA, LAMA, or theophylline
4. Prebronchodilator forced expiratory volume in 1 second (FEV1) of ≥40 to \<90% predicted normal value for adults and adolescents, and ≥60 to \<100% predicted normal value for subjects aged 4 to 11 years after withholding specified medications including short/rapid-acting β2-adrenoreceptor agonist (SABA)
5. Demonstrate reversibility at Visit 1, with an increase in FEV1 ≥12% (and ≥200 mL for subjects aged ≥18 years) relative to baseline after administration of sponsor provided Ventolin via central spirometry. One re-test for reversibility testing is allowed within the screening period in advance of Visit 2
6. Demonstrate acceptable spirometry performance (i.e., meet American Thoracic Society/European Respiratory Society acceptability/repeatability criteria)
7. A documented history of at least 1 severe asthma exacerbation within 12 months before Visit 1
8. Able to perform acceptable and reproducible peak expiratory flow (PEF) measurements as assessed by the investigator

Exclusion Criteria

1. Chronic obstructive pulmonary disease or other significant lung disease (e.g., chronic bronchitis, emphysema, bronchiectasis with the need of treatment, cystic fibrosis, or bronchopulmonary dysplasia)
2. Oral corticosteroid/SCS use (any dose and any indication) within 6 weeks before Visit 1
3. Chronic use of oral corticosteroids (OCS, ≥3 weeks use in 3 months prior to Visit 1)
4. Having received any marketed (e.g., omalizumab, mepolizumab, reslizumab, benralizumab) or investigational biologic within 3 months or any other prohibited medication
5. Current smokers, former smokers with \>10 pack-years history, or former smokers who stopped smoking \<6 months before Visit 1 (including all forms of tobacco, e-cigarettes \[vaping\], and marijuana)
6. Life-threatening asthma defined as any history of significant asthma episode(s) requiring intubation associated with hypercapnia, respiratory arrest, hypoxic seizures, or asthma related syncopal episode(s) within 5 years of Visit 1
7. Historical or current evidence of a clinically significant disease
8. Cancer not in complete remission for at least 5 years
9. Hospitalization for psychiatric disorder or attempted suicide within 1 year of Visit 1
10. History of psychiatric disease, intellectual deficiency, poor motivation, or other conditions if their magnitude is limiting informed consent validity
11. Significant abuse of alcohol or drugs
Minimum Eligible Age

4 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bond Avillion 2 Development LP

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Frank Albers, MD, PhD

Role: STUDY_DIRECTOR

Avillion LLP

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Birmingham, Alabama, United States

Site Status

Research Site

Huntsville, Alabama, United States

Site Status

Research Site

Mobile, Alabama, United States

Site Status

Research Site

Montgomery, Alabama, United States

Site Status

Research Site

Scottsboro, Alabama, United States

Site Status

Research Site

Sheffield, Alabama, United States

Site Status

Research Site

Tuscumbia, Alabama, United States

Site Status

Research Site

Glendale, Arizona, United States

Site Status

Research Site

Peoria, Arizona, United States

Site Status

Research Site

Scottsdale, Arizona, United States

Site Status

Research Site

Little Rock, Arkansas, United States

Site Status

Research Site

Bakersfield, California, United States

Site Status

Research Site

Bellflower, California, United States

Site Status

Research Site

Canoga Park, California, United States

Site Status

Research Site

Encinitas, California, United States

Site Status

Research Site

Hawthorne, California, United States

Site Status

Research Site

Long Beach, California, United States

Site Status

Research Site

Los Angeles, California, United States

Site Status

Research Site

Los Angeles, California, United States

Site Status

Research Site

Los Angeles, California, United States

Site Status

Research Site

Newport Beach, California, United States

Site Status

Research Site

Rancho Cucamonga, California, United States

Site Status

Research Site

Redwood City, California, United States

Site Status

Research Site

Sacramento, California, United States

Site Status

Research Site

San Diego, California, United States

Site Status

Research Site

San Francisco, California, United States

Site Status

Research Site

San Jose, California, United States

Site Status

Research Site

Westminster, California, United States

Site Status

Research Site

Aurora, Colorado, United States

Site Status

Research Site

Colorado Springs, Colorado, United States

Site Status

Research Site

Colorado Springs, Colorado, United States

Site Status

Research Site

Denver, Colorado, United States

Site Status

Research Site

Denver, Colorado, United States

Site Status

Research Site

Denver, Colorado, United States

Site Status

Research Site

Waterbury, Connecticut, United States

Site Status

Research Site

Aventura, Florida, United States

Site Status

Research Site

Boynton Beach, Florida, United States

Site Status

Research Site

Cape Coral, Florida, United States

Site Status

Research Site

Clearwater, Florida, United States

Site Status

Research Site

Clearwater, Florida, United States

Site Status

Research Site

DeLand, Florida, United States

Site Status

Research Site

Gainesville, Florida, United States

Site Status

Research Site

Greenacres City, Florida, United States

Site Status

Research Site

Hialeah, Florida, United States

Site Status

Research Site

Kissimmee, Florida, United States

Site Status

Research Site

Miami, Florida, United States

Site Status

Research Site

Miami, Florida, United States

Site Status

Research Site

Miami, Florida, United States

Site Status

Research Site

Miami, Florida, United States

Site Status

Research Site

Miami, Florida, United States

Site Status

Research Site

Miami, Florida, United States

Site Status

Research Site

Miami, Florida, United States

Site Status

Research Site

Miami, Florida, United States

Site Status

Research Site

Orlando, Florida, United States

Site Status

Research Site

Orlando, Florida, United States

Site Status

Research Site

Oviedo, Florida, United States

Site Status

Research Site

Palmetto Bay, Florida, United States

Site Status

Research Site

Panama City, Florida, United States

Site Status

Research Site

Pembroke Pines, Florida, United States

Site Status

Research Site

Pembroke Pines, Florida, United States

Site Status

Research Site

St. Petersburg, Florida, United States

Site Status

Research Site

St. Petersburg, Florida, United States

Site Status

Research Site

Albany, Georgia, United States

Site Status

Research Site

Winder, Georgia, United States

Site Status

Research Site

Meridian, Idaho, United States

Site Status

Research Site

Chicago, Illinois, United States

Site Status

Research Site

Normal, Illinois, United States

Site Status

Research Site

Iowa City, Iowa, United States

Site Status

Research Site

Overland Park, Kansas, United States

Site Status

Research Site

Topeka, Kansas, United States

Site Status

Research Site

Owensboro, Kentucky, United States

Site Status

Research Site

Bangor, Maine, United States

Site Status

Research Site

Baltimore, Maryland, United States

Site Status

Research Site

Chevy Chase, Maryland, United States

Site Status

Research Site

White Marsh, Maryland, United States

Site Status

Research Site

Boston, Massachusetts, United States

Site Status

Research Site

Fall River, Massachusetts, United States

Site Status

Research Site

North Dartmouth, Massachusetts, United States

Site Status

Research Site

Ann Arbor, Michigan, United States

Site Status

Research Site

Ann Arbor, Michigan, United States

Site Status

Research Site

Farmington Hills, Michigan, United States

Site Status

Research Site

Flint, Michigan, United States

Site Status

Research Site

Flint, Michigan, United States

Site Status

Research Site

Hamtramck, Michigan, United States

Site Status

Research Site

Rochester, Michigan, United States

Site Status

Research Site

Rochester Hills, Michigan, United States

Site Status

Research Site

Ypsilanti, Michigan, United States

Site Status

Research Site

Hazelwood, Missouri, United States

Site Status

Research Site

St Louis, Missouri, United States

Site Status

Research Site

St Louis, Missouri, United States

Site Status

Research Site

Bellevue, Nebraska, United States

Site Status

Research Site

Bellevue, Nebraska, United States

Site Status

Research Site

Lincoln, Nebraska, United States

Site Status

Research Site

Las Vegas, Nevada, United States

Site Status

Research Site

Brick, New Jersey, United States

Site Status

Research Site

Marlton, New Jersey, United States

Site Status

Research Site

New Brunswick, New Jersey, United States

Site Status

Research Site

Toms River, New Jersey, United States

Site Status

Research Site

Albuquerque, New Mexico, United States

Site Status

Research Site

Brooklyn, New York, United States

Site Status

Research Site

New Hyde Park, New York, United States

Site Status

Research Site

Potsdam, New York, United States

Site Status

Research Site

The Bronx, New York, United States

Site Status

Research Site

Asheville, North Carolina, United States

Site Status

Research Site

Charlotte, North Carolina, United States

Site Status

Research Site

Charlotte, North Carolina, United States

Site Status

Research Site

Charlotte, North Carolina, United States

Site Status

Research Site

Gastonia, North Carolina, United States

Site Status

Research Site

High Point, North Carolina, United States

Site Status

Research Site

Monroe, North Carolina, United States

Site Status

Research Site

Raleigh, North Carolina, United States

Site Status

Research Site

Winston-Salem, North Carolina, United States

Site Status

Research Site

Fargo, North Dakota, United States

Site Status

Research Site

Cincinnati, Ohio, United States

Site Status

Research Site

Cincinnati, Ohio, United States

Site Status

Research Site

Columbus, Ohio, United States

Site Status

Research Site

Dayton, Ohio, United States

Site Status

Research Site

Dayton, Ohio, United States

Site Status

Research Site

Dublin, Ohio, United States

Site Status

Research Site

Mayfield Heights, Ohio, United States

Site Status

Research Site

Edmond, Oklahoma, United States

Site Status

Research Site

Oklahoma City, Oklahoma, United States

Site Status

Research Site

Tulsa, Oklahoma, United States

Site Status

Research Site

Medford, Oregon, United States

Site Status

Research Site

Blue Bell, Pennsylvania, United States

Site Status

Research Site

Erie, Pennsylvania, United States

Site Status

Research Site

Philadelphia, Pennsylvania, United States

Site Status

Research Site

Pittsburgh, Pennsylvania, United States

Site Status

Research Site

East Providence, Rhode Island, United States

Site Status

Research Site

Providence, Rhode Island, United States

Site Status

Research Site

Warwick, Rhode Island, United States

Site Status

Research Site

Anderson, South Carolina, United States

Site Status

Research Site

Clinton, South Carolina, United States

Site Status

Research Site

Columbia, South Carolina, United States

Site Status

Research Site

Gaffney, South Carolina, United States

Site Status

Research Site

Greenville, South Carolina, United States

Site Status

Research Site

Mt. Pleasant, South Carolina, United States

Site Status

Research Site

Myrtle Beach, South Carolina, United States

Site Status

Research Site

North Charleston, South Carolina, United States

Site Status

Research Site

Pelzer, South Carolina, United States

Site Status

Research Site

Rock Hill, South Carolina, United States

Site Status

Research Site

Spartanburg, South Carolina, United States

Site Status

Research Site

Austin, Texas, United States

Site Status

Research Site

Austin, Texas, United States

Site Status

Research Site

Beaumont, Texas, United States

Site Status

Research Site

Boerne, Texas, United States

Site Status

Research Site

Conroe, Texas, United States

Site Status

Research Site

Corsicana, Texas, United States

Site Status

Research Site

Dallas, Texas, United States

Site Status

Research Site

Dallas, Texas, United States

Site Status

Research Site

Dallas, Texas, United States

Site Status

Research Site

El Paso, Texas, United States

Site Status

Research Site

Galveston, Texas, United States

Site Status

Research Site

Houston, Texas, United States

Site Status

Research Site

Kerrville, Texas, United States

Site Status

Research Site

Live Oak, Texas, United States

Site Status

Research Site

McKinney, Texas, United States

Site Status

Research Site

Pearland, Texas, United States

Site Status

Research Site

San Antonio, Texas, United States

Site Status

Research Site

San Antonio, Texas, United States

Site Status

Research Site

Sherman, Texas, United States

Site Status

Research Site

The Woodlands, Texas, United States

Site Status

Research Site

Tomball, Texas, United States

Site Status

Research Site

Waco, Texas, United States

Site Status

Research Site

Waxahachie, Texas, United States

Site Status

Research Site

Murray, Utah, United States

Site Status

Research Site

Salt Lake City, Utah, United States

Site Status

Research Site

South Burlington, Vermont, United States

Site Status

Research Site

Morgantown, West Virginia, United States

Site Status

Research Site

Greenfield, Wisconsin, United States

Site Status

Research Site

Buenos Aires, , Argentina

Site Status

Research Site

Buenos Aires, , Argentina

Site Status

Research Site

Buenos Aires, , Argentina

Site Status

Research Site

Buenos Aires, , Argentina

Site Status

Research Site

Buenos Aires, , Argentina

Site Status

Research Site

Buenos Aires, , Argentina

Site Status

Research Site

Córdoba, , Argentina

Site Status

Research Site

Lanús, , Argentina

Site Status

Research Site

Mar del Plata, , Argentina

Site Status

Research Site

Mendoza, , Argentina

Site Status

Research Site

Mendoza, , Argentina

Site Status

Research Site

Quilmes, , Argentina

Site Status

Research Site

Rosario, , Argentina

Site Status

Research Site

Rosario, , Argentina

Site Status

Research Site

Rosario, , Argentina

Site Status

Research Site

Salta, , Argentina

Site Status

Research Site

San Fernando, , Argentina

Site Status

Research Site

San Juan Bautista, , Argentina

Site Status

Research Site

San Miguel de Tucumán, , Argentina

Site Status

Research Site

San Miguel de Tucumán, , Argentina

Site Status

Research Site

San Miguel de Tucumán, , Argentina

Site Status

Research Site

Santa Fe, , Argentina

Site Status

Research Site

Santa Fe, , Argentina

Site Status

Research Site

Vancouver, British Columbia, Canada

Site Status

Research Site

Ajax, Ontario, Canada

Site Status

Research Site

Burlington, Ontario, Canada

Site Status

Research Site

Greater Sudbury, Ontario, Canada

Site Status

Research Site

London, Ontario, Canada

Site Status

Research Site

Newmarket, Ontario, Canada

Site Status

Research Site

Toronto, Ontario, Canada

Site Status

Research Site

Waterloo, Ontario, Canada

Site Status

Research Site

Windsor, Ontario, Canada

Site Status

Research Site

Québec, Quebec, Canada

Site Status

Research Site

Beroun, , Czechia

Site Status

Research Site

Brandýs nad Labem, , Czechia

Site Status

Research Site

Jindřichův Hradec, , Czechia

Site Status

Research Site

Kralupy nad Vltavou, , Czechia

Site Status

Research Site

Kuřim, , Czechia

Site Status

Research Site

Lovosice, , Czechia

Site Status

Research Site

Miroslav, , Czechia

Site Status

Research Site

Neratovice, , Czechia

Site Status

Research Site

Prague, , Czechia

Site Status

Research Site

Prague, , Czechia

Site Status

Research Site

Rokycany, , Czechia

Site Status

Research Site

Tábor, , Czechia

Site Status

Research Site

Teplice, , Czechia

Site Status

Research Site

Varnsdorf, , Czechia

Site Status

Research Site

Augsburg, , Germany

Site Status

Research Site

Bad Wörishofen, , Germany

Site Status

Research Site

Bamberg, , Germany

Site Status

Research Site

Bergisch Gladbach, , Germany

Site Status

Research Site

Berlin, , Germany

Site Status

Research Site

Berlin, , Germany

Site Status

Research Site

Berlin, , Germany

Site Status

Research Site

Berlin, , Germany

Site Status

Research Site

Berlin, , Germany

Site Status

Research Site

Berlin, , Germany

Site Status

Research Site

Berlin, , Germany

Site Status

Research Site

Berlin, , Germany

Site Status

Research Site

Berlin, , Germany

Site Status

Research Site

Bonn, , Germany

Site Status

Research Site

Cologne, , Germany

Site Status

Research Site

Cottbus, , Germany

Site Status

Research Site

Darmstadt, , Germany

Site Status

Research Site

Delitzsch, , Germany

Site Status

Research Site

Dortmund, , Germany

Site Status

Research Site

Essen, , Germany

Site Status

Research Site

Frankfurt, , Germany

Site Status

Research Site

Frankfurt, , Germany

Site Status

Research Site

Geesthacht, , Germany

Site Status

Research Site

Gelsenkirchen, , Germany

Site Status

Research Site

Halle, , Germany

Site Status

Research Site

Hamburg, , Germany

Site Status

Research Site

Hamburg, , Germany

Site Status

Research Site

Hanover, , Germany

Site Status

Research Site

Hanover, , Germany

Site Status

Research Site

Homburg, , Germany

Site Status

Research Site

Jena, , Germany

Site Status

Research Site

Leipzig, , Germany

Site Status

Research Site

Leipzig, , Germany

Site Status

Research Site

Leipzig, , Germany

Site Status

Research Site

Leipzig, , Germany

Site Status

Research Site

Leipzig, , Germany

Site Status

Research Site

Lübeck, , Germany

Site Status

Research Site

Lübeck, , Germany

Site Status

Research Site

Magdeburg, , Germany

Site Status

Research Site

Marburg, , Germany

Site Status

Research Site

München, , Germany

Site Status

Research Site

München, , Germany

Site Status

Research Site

Neu-Isenburg, , Germany

Site Status

Research Site

Peine, , Germany

Site Status

Research Site

Potsdam, , Germany

Site Status

Research Site

Radebeul, , Germany

Site Status

Research Site

Reinfeld, , Germany

Site Status

Research Site

Rosenheim, , Germany

Site Status

Research Site

Schleswig, , Germany

Site Status

Research Site

Wiesbaden, , Germany

Site Status

Research Site

Witten, , Germany

Site Status

Research Site

Belgrade, , Serbia

Site Status

Research Site

Kamenitz, , Serbia

Site Status

Research Site

Kragujevac, , Serbia

Site Status

Research Site

Niš, , Serbia

Site Status

Research Site

Valjevo, , Serbia

Site Status

Research Site

Bratislava, , Slovakia

Site Status

Research Site

Ilava, , Slovakia

Site Status

Research Site

Kežmarok, , Slovakia

Site Status

Research Site

Košice, , Slovakia

Site Status

Research Site

Košice, , Slovakia

Site Status

Research Site

Poprad, , Slovakia

Site Status

Research Site

Prešov, , Slovakia

Site Status

Research Site

Žilina, , Slovakia

Site Status

Research Site

Athlone, , South Africa

Site Status

Research Site

Bellville, , South Africa

Site Status

Research Site

Benoni, , South Africa

Site Status

Research Site

Bloemfontein, , South Africa

Site Status

Research Site

Boksburg, , South Africa

Site Status

Research Site

Cape Town, , South Africa

Site Status

Research Site

Cape Town, , South Africa

Site Status

Research Site

Durban, , South Africa

Site Status

Research Site

Durban, , South Africa

Site Status

Research Site

eMkhomazi, , South Africa

Site Status

Research Site

Gatesville, , South Africa

Site Status

Research Site

Johannesburg, , South Africa

Site Status

Research Site

Kempton Park, , South Africa

Site Status

Research Site

Kraaifontein, , South Africa

Site Status

Research Site

Middelburg, , South Africa

Site Status

Research Site

Mowbray, , South Africa

Site Status

Research Site

Newtown, , South Africa

Site Status

Research Site

Parktown, , South Africa

Site Status

Research Site

Pretoria, , South Africa

Site Status

Research Site

Pretoria, , South Africa

Site Status

Research Site

Roodepoort, , South Africa

Site Status

Research Site

Umhlanga, , South Africa

Site Status

Research Site

Witbank, , South Africa

Site Status

Research Site

Barcelona, , Spain

Site Status

Research Site

Barcelona, , Spain

Site Status

Research Site

Barcelona, , Spain

Site Status

Research Site

Barcelona, , Spain

Site Status

Research Site

Girona, , Spain

Site Status

Research Site

Madrid, , Spain

Site Status

Research Site

Mérida, , Spain

Site Status

Research Site

Valencia, , Spain

Site Status

Research Site

Cherkasy, , Ukraine

Site Status

Research Site

Dnipro, , Ukraine

Site Status

Research Site

Ivano-Frankivsk, , Ukraine

Site Status

Research Site

Kharkiv, , Ukraine

Site Status

Research Site

Kharkiv, , Ukraine

Site Status

Research Site

Kharkiv, , Ukraine

Site Status

Research Site

Kherson, , Ukraine

Site Status

Research Site

Kyiv, , Ukraine

Site Status

Research Site

Kyiv, , Ukraine

Site Status

Research Site

Kyiv, , Ukraine

Site Status

Research Site

Lutsk, , Ukraine

Site Status

Research Site

Uzhhorod, , Ukraine

Site Status

Research Site

Vinnytsia, , Ukraine

Site Status

Research Site

Zaporizhzhya, , Ukraine

Site Status

Research Site

Zaporizhzhya, , Ukraine

Site Status

Research Site

Zaporizhzhya, , Ukraine

Site Status

Research Site

Belfast, , United Kingdom

Site Status

Research Site

Blackpool, , United Kingdom

Site Status

Research Site

Bradford, , United Kingdom

Site Status

Research Site

Chippenham, , United Kingdom

Site Status

Research Site

Corby, , United Kingdom

Site Status

Research Site

Corby, , United Kingdom

Site Status

Research Site

Kenilworth, , United Kingdom

Site Status

Research Site

Liverpool, , United Kingdom

Site Status

Research Site

London, , United Kingdom

Site Status

Research Site

Newcastle upon Tyne, , United Kingdom

Site Status

Research Site

Northwood, , United Kingdom

Site Status

Research Site

Nottingham, , United Kingdom

Site Status

Research Site

Peterborough, , United Kingdom

Site Status

Research Site

Romford, , United Kingdom

Site Status

Research Site

Shipley, , United Kingdom

Site Status

Research Site

Sidcup, , United Kingdom

Site Status

Research Site

Wokingham, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Canada Czechia Germany Serbia Slovakia South Africa Spain Ukraine United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Chipps BE, Albers FC, Reilly L, Johnsson E, Cappelletti C, Papi A. Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged >/=4 years with moderate-to-severe asthma: rationale and design of the randomised, double-blind, active-controlled MANDALA study. BMJ Open Respir Res. 2021 Dec;8(1):e001077. doi: 10.1136/bmjresp-2021-001077.

Reference Type BACKGROUND
PMID: 34887317 (View on PubMed)

Papi A, Chipps BE, Beasley R, Panettieri RA Jr, Israel E, Cooper M, Dunsire L, Jeynes-Ellis A, Johnsson E, Rees R, Cappelletti C, Albers FC. Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. N Engl J Med. 2022 Jun 2;386(22):2071-2083. doi: 10.1056/NEJMoa2203163. Epub 2022 May 15.

Reference Type RESULT
PMID: 35569035 (View on PubMed)

Chipps BE, Panettieri RA Jr, Skolnik N, Cappelletti C, Daoud SZ, Dunsire L, Gilbert IA, Papi A. Albuterol-budesonide rescue inhaler for asthma: Patterns of use and safety in the MANDALA trial. Ann Allergy Asthma Immunol. 2025 Jul 13:S1081-1206(25)00348-5. doi: 10.1016/j.anai.2025.07.008. Online ahead of print.

Reference Type DERIVED
PMID: 40664332 (View on PubMed)

Kew KM, Flemyng E, Quon BS, Leung C. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD007524. doi: 10.1002/14651858.CD007524.pub5.

Reference Type DERIVED
PMID: 36161875 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AV003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.